|« Previous month||Next month »|
30-Nov-2011 - Aurobindo Pharma says a fire that broke out at its manufacturing plant in India injuring three employees did not disrupt production operations.
30-Nov-2011 - Ideal Cures says its new Instacoat E Series film can cut tablet coating times in half and save manufacturers money.
30-Nov-2011 - Novo Nordisk has stopped using living animals in batch quality tests after developing a virus filtration tool for factor VII production.
30-Nov-2011 - Taste masking plays a vital role in treatment compliance according to Cargill, which has launched a new flavour technology that it claims can make drugs more pleasant to take and...
29-Nov-2011 - High potency APIs are becoming a key focus of the pharmaceutical business, with drug makers from all areas racing to establish a foothold in the market.
29-Nov-2011 - The USPTO has rejected MonoSol RX’s claims that production methods for a cancer pain patch developed by BioDelivery Sciences (BDSI) infringe on manufacturing techniques it uses to make its own...
29-Nov-2011 - USP is creating a China-focused East Asia expert committee to develop quality standards for excipients.
28-Nov-2011 - in-PharmaTechnologist presents its round-up of the latest drug delivery research developments in the pharmaceutical world, including tumour targeting peptides and lipid nanoparticle drug-delivery technology.
28-Nov-2011 - Generic drugs manufacturer SOHM is continuing its expansion into the Indian market with the acquisition of Novatrend Medicament’s product line.
28-Nov-2011 - Industry reluctance to share information on economic adulteration is hindering FDA efforts to tackle tainted ingredients, a GAO report found.
24-Nov-2011 - The EC is seeking industry comments before implementing the serialisation aspect of the falsified medicines directive.
24-Nov-2011 - Biocon is close to signing an agreement with a partner willing to inject cash into its experimental insulin pill, said its MD.
24-Nov-2011 - in-PharmaTechnologist presents its weekly line-up of the latest appointments in the pharmaceutical industry, including news from Genesis, Acino and Pharmalink AB.
24-Nov-2011 - A Pfizer Ireland plant has become the first in its network to achieve ISO accreditation for cutting CO2 emissions and energy use.
23-Nov-2011 - pSivida has inked a technology evaluation agreement with an unnamed global pharma over its Durasert drug delivery technology.
23-Nov-2011 - GlaxoSmithKline (GSK) has urged the US FDA consider the absorption of nanomaterials in the gastrointestinal (GI) tract within its proposal for new regulations on nanotechnology.
23-Nov-2011 - The EMA is recalling cancer drugs manufactured by CMO Ben Venue Laboratories after inspectors found quality shortcomings.
23-Nov-2011 - Shire has submitted EMA and FDA regulatory filings to add ‘substantial manufacturing capacity’ for Vpriv (velaglucerase alfa).
23-Nov-2011 - The US FDA has sent Mylan a warning letter after inspectors found GMP testing failings at its Puerto Rico facility.
22-Nov-2011 - German technology giant Schott has signed an agreement with a Chinese firm to provide the fast-growing pharmaceutical market with a range of high-end glass packaging products.
22-Nov-2011 - FDA draft guidance defines nanoparticles too broadly and could result in APIs being categorised as nanomaterials, industry said.
22-Nov-2011 - Biocon has begun selling a reusable insulin pen, based on Haselmeier technology, to patients in India.
22-Nov-2011 - Novavax is leasing a cGMP plant in Maryland under ‘very favourable terms’ to meet anticipated demand for its VLP vaccines.
21-Nov-2011 - Gold nanoparticles can target endothelial cells to cut the supply of oxygen to most types of tumour, according to a new study.
21-Nov-2011 - Ben Venue Laboratories has voluntarily suspended manufacture at the Ohio plant linked to drug shortages.
|« Previous month||Next month »|